Trials / Not Yet Recruiting
Not Yet RecruitingNCT07282002
Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis
Feasibility Protocol for Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Angiodynamics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigation aims to demonstrate initial safety and efficacy of the AngioVac System for the removal of vegetation in the right heart in patients with infective endocarditis.
Detailed description
This is a prospective, multicenter, single-arm investigational device study evaluating safety and effectiveness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AngioVac System | Percutaneous vacuum-assisted aspiration of right-sided vegetation via suction, filtration and veno-venous bypass. |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2026-11-01
- Completion
- 2027-03-01
- First posted
- 2025-12-15
- Last updated
- 2025-12-15
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07282002. Inclusion in this directory is not an endorsement.